Literature DB >> 9673562

Pattern of recurrence after resection for intraductal papillary mucinous tumors of the pancreas.

M Sho1, Y Nakajima, H Kanehiro, M Hisanaga, K Nishio, M Nagao, N Ikeda, H Kanokogi, T Yamada, H Nakano.   

Abstract

The objective of this study was to clarify the patterns of recurrence and prognosis after resection of intraductal papillary mucinous tumors (IPMTs). Fourteen patients with IPMT were reviewed histologically; intraductal papillary adenocarcinoma was present in 12 cases and intraductal papillary adenoma in 2. Six patients were alive with no evidence of disease. Two patients died from other causes. Six patients had recurrences. The median survival time was 46 months. In the six recurrent cases, the median postoperative disease-free interval was 38 months. Four patients died of recurrence, and the median survival time after recurrence was 6 months. The major site of recurrence was the remnant pancreas. The other sites were the liver in two cases, peritoneum in two, and local in one. These results suggest the multicentric or metachronous oncogenesis of IPMT. Because of the low frequency of lymph node metastases, an operation to preserve pancreatic function may be recommended, especially for localized tumors such as the branch type. It is important to avoid an incomplete resection using intraoperative pancreatoscopy and ultrasonography. Long-term follow-up after surgery is necessary even for a curative resection. We should perform total pancreatectomy for recurrences without distant metastases.

Entities:  

Mesh:

Year:  1998        PMID: 9673562     DOI: 10.1007/s002689900485

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  23 in total

Review 1.  Cystic lesions in the pancreas: when to watch, when to resect.

Authors:  J H Balcom IV; C Fernandez-Del Castillo; A L Warshaw
Journal:  Curr Gastroenterol Rep       Date:  2000-04

2.  Intraductal papillary mucinous neoplasms of the pancreas.

Authors:  Jose G Trevino; N Joseph Espat; W Scott Helton
Journal:  Curr Treat Options Gastroenterol       Date:  2006-09

3.  Total pancreatectomy for pancreatic cancer: indications and operative technique.

Authors:  Yakup Kulu; Bruno M Schmied; Jens Werner; Pietro Muselli; Markus W Büchler; Jan Schmidt
Journal:  HPB (Oxford)       Date:  2009-09       Impact factor: 3.647

4.  Minute invasive ductal carcinoma of the residual pancreas after distal pancreatectomy for intraductal papillary-mucinous tumor.

Authors:  Toshiyuki Moriya; Wataru Kimura; Fumiaki Sakurai; Shuho Semba; Koichiro Ozawa; Ichiro Hirai; Akira Fuse
Journal:  Int J Gastrointest Cancer       Date:  2002

5.  Intraductal papillary mucinous neoplasms of the pancreas: an analysis of clinicopathologic features and outcome.

Authors:  Michael D'Angelica; Murray F Brennan; Arief A Suriawinata; David Klimstra; Kevin C Conlon
Journal:  Ann Surg       Date:  2004-03       Impact factor: 12.969

6.  Consensus guidelines in the management of branch duct intraductal papillary mucinous neoplasm: a cost-effectiveness analysis.

Authors:  Edward S Huang; G Scott Gazelle; Chin Hur
Journal:  Dig Dis Sci       Date:  2009-10-16       Impact factor: 3.199

Review 7.  Management of mucin-producing cystic neoplasms of the pancreas.

Authors:  Stefan Fritz; Andrew L Warshaw; Sarah P Thayer
Journal:  Oncologist       Date:  2009-02-11

8.  Total pancreatectomy for recurrent intraductal papillary mucinous carcinoma in remnant pancreas of pancreaticoduodenectomy for intraductal papillary mucinous adenocarcinoma.

Authors:  Yu Ohkura; Kazunari Sasaki; Masamichi Matsuda; Masaji Hashimoto
Journal:  BMJ Case Rep       Date:  2013-05-23

Review 9.  Malignant potential of intraductal papillary mucinous neoplasms of the pancreas.

Authors:  Yoshiyuki Nakajima; Takatsugu Yamada; Masayuki Sho
Journal:  Surg Today       Date:  2010-08-26       Impact factor: 2.549

Review 10.  Natural history of intraductal papillary mucinous neoplasms (IPMN): current evidence and implications for management.

Authors:  Claudio Bassi; Michael G Sarr; Keith D Lillemoe; Howard A Reber
Journal:  J Gastrointest Surg       Date:  2007-12-19       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.